Turmeric for Hepatitis C, and Beyond
Jun 27, 2016
4 Comments
Turmeric is the ultimate anti-inflammatory spice that protects liver cells from Hep C – and does so much more.
Continue reading »
Research & Treatment News
Share
Follow Us
Need for Liver Transplants Is Decreasing With New Hep C Drugs
Will the new HCV drugs continue to decrease liver transplant waiting lists?
Continue reading »
New Study Debunks Negative Hep C Stigma
Jun 2, 2016
42 Comments
In baby boomers, Hepatitis C infection appears to be a casualty of modern medicine’s evolution – not a consequence of risky behavior.
Continue reading »
Hepatitis Awareness Month 2016
May 19th has been designated as a national “Hepatitis Testing Day” in the United States.
Continue reading »
Low-Cost Generic HCV Drugs Are Safe and Effective
Apr 25, 2016
4 Comments
Did you know that generic antiviral drugs for Hepatitis C patients are just as effective as their brand-name versions (Sovaldi, Daklinza and Rebetol)?
Continue reading »
Hep C Tests Predict Best Meds
Apr 18, 2016
4 Comments
The Hepatitis C virus can mutate and become drug resistant. But new tests could enable physicians to stay one step ahead by predicting the best medication based on the specific HCV strain.
Continue reading »
First Ultrasound Contrast Agent Approved by FDA for Liver Imaging
Apr 15, 2016
2 Comments
Learn more about Lumaso, and it's FDA approval for enhanced liver ultrasound in patients.
Continue reading »
Acupuncture + Curcumin = Potent Duo for Liver Health
Apr 4, 2016
8 Comments
Discover how liver fibrosis is reduced with a combo of approaches that lie outside of conventional medicine.
Continue reading »
Key Outcome of HCV Trial: BIT225 Was Safe and Well-Tolerated
Mar 18, 2016
2 Comments
Find out why BIT225 might potentially be used in combination with new Hepatitis C drugs to help shorten treatment times and improve treatment outcomes.
Continue reading »
Drug Candidate Emricasan to Stop Progression of Liver Disease
Mar 3, 2016
1 Comment
Learn how Emricasan, a first-in-class, orally active caspase protease inhibitor, offers the untapped medical need to stop liver fibrosis, nonalcoholic steatohepatitis (NASH) and cirrhosis.
Continue reading »
